Compile Data Set for Download or QSAR
Report error Found 36 Enz. Inhib. hit(s) with all data for entry = 11615
TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633204(5-(4-(1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-3-(3-(...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633224(4-(((Z)-4-amino-2-fluorobut-2-en-1-yl)sulfonyl)-N-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633224(4-(((Z)-4-amino-2-fluorobut-2-en-1-yl)sulfonyl)-N-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633227(2-(((Z)-4-amino-2-fluorobut-2-en-1-yl)sulfonyl)-N-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633202(N,N′-((((5-(1-((Z)-4-amino-2-fluorobut-2-en-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633203(5-(1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-3-(3-(N,N...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633203(5-(1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-3-(3-(N,N...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633204(5-(4-(1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-3-(3-(...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633244(3-(((Z)-4-amino-2-fluorobut-2-en-1-yl)sulfonyl)-N-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633245((3aS,4S,6aR)-4-(5-(4-(3-(3-(((Z)-4-amino-2-fluorob...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633245((3aS,4S,6aR)-4-(5-(4-(3-(3-(((Z)-4-amino-2-fluorob...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633246((3aS,3a'S,4S,4'S,6aR,6a′R)-4,4′-(((((5...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633227(2-(((Z)-4-amino-2-fluorobut-2-en-1-yl)sulfonyl)-N-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633233(3-(((Z)-4-amino-2-fluorobut-2-en-1-yl)sulfonyl)-N-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633233(3-(((Z)-4-amino-2-fluorobut-2-en-1-yl)sulfonyl)-N-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633244(3-(((Z)-4-amino-2-fluorobut-2-en-1-yl)sulfonyl)-N-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633181(1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-3-(3-(N,N-di...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633197(N,N′-((((((((((5-(1-((Z)-4-amino-2-fluorobut...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633197(N,N′-((((((((((5-(1-((Z)-4-amino-2-fluorobut...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633202(N,N′-((((5-(1-((Z)-4-amino-2-fluorobut-2-en-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633180(4-((1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-2-methyl...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633180(4-((1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-2-methyl...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633181(1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-3-(3-(N,N-di...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633247((3aS,3a'S,4S,4'S,6aR,6a′R)-4,4′-(((((3...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633247((3aS,3a'S,4S,4'S,6aR,6a′R)-4,4′-(((((3...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633248((3aS,4S,6aR)-4-(4-(4-(3-((3-(((Z)-4-amino-2-fluoro...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633248((3aS,4S,6aR)-4-(4-(4-(3-((3-(((Z)-4-amino-2-fluoro...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 1(Human)
Pharmaxis

US Patent
LigandPNGBDBM633246((3aS,3a'S,4S,4'S,6aR,6a′R)-4,4′-(((((5...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633246((3aS,3a'S,4S,4'S,6aR,6a′R)-4,4′-(((((5...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM633246((3aS,3a'S,4S,4'S,6aR,6a′R)-4,4′-(((((5...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 4(Human)
Pharmaxis

US Patent
LigandPNGBDBM633246((3aS,3a'S,4S,4'S,6aR,6a′R)-4,4′-(((((5...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633250(N-((1-(4-(((1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633249(N-((1-(4-(((1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 2(Human)
Pharmaxis

US Patent
LigandPNGBDBM633249(N-((1-(4-(((1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetLysyl oxidase homolog 3(Human)
Pharmaxis

US Patent
LigandPNGBDBM633249(N-((1-(4-(((1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetProtein-lysine 6-oxidase(Bovine)
Pharmaxis

US Patent
LigandPNGBDBM633250(N-((1-(4-(((1-((Z)-4-amino-2-fluorobut-2-en-1-yl)-...)
Affinity DataIC50: 300nMAssay Description:The assay was developed using either 384 or 96 well format. Briefly, in a standard 384 well plate assay 25 μL of a dilution of any of the isoenz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent